20 October 2021 |
|
|
|
INSPIRATION HEALTHCARE GROUP PLC
(the "Company")
Directors / PDMR Dealing
The Company has been notified that Toby Foster, VP Strategic Opportunities and a person discharging managerial responsibility ("PDMR") in the Company, on Friday 15th October sold 75,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") and on Monday 18th October sold 30,000 Ordinary Shares and on Wednesday 20th October sold 30,000 Ordinary Shares. Mr Foster has therefore sold a total of 135,000 Ordinary Shares at a weighted average price of 141.9 pence per share .
Following the sale, Mr Foster retains an interest in 3,300,283 Ordinary Shares, representing approximately 4.86 per cent. of the Company's issued ordinary share capital.
This announcement, including the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation.
1 |
|
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||
a. |
Name |
|
Toby Foster |
||||||||
2 |
Reason for notification |
|
|
||||||||
a. |
Position/Status |
|
VP Strategic Opportunities of Inspiration Healthcare Group plc |
||||||||
b. |
Initial notification/ Amendment |
|
Initial Notification |
||||||||
3 |
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a. |
Name |
|
INSPIRATION HEALTHCARE GROUP PLC
|
||||||||
b. |
LEI |
|
213800GKFT3ENAPMDL15 |
||||||||
4 |
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a. |
Description of the financial instrument, type of instrument |
|
Ordinary Shares of 10 p each
ISIN: GB00BXDZL105 |
||||||||
b. |
Nature of the transaction |
|
Sale of Ordinary Shares |
||||||||
c. |
Price(s) and volume(s) |
|
|
|
|
|
|
||||
|
Price(s) |
Volume(s) |
Date |
|
|||||||
143p 144p 145.5p 140p 138p |
25,000 25,000 25,000 30,000 30,000 |
15th October 2021 15th October 2021 15th October 2021 18th October 2021 20th October 2021 |
|
||||||||
|
|
||||||||||
d. |
Aggregated information - Aggregated Volume - Price
|
|
135,000 Ordinary Shares 141.9p (weighted average) |
||||||||
e. |
Date of the transaction |
|
15th October 2021, 18th October 2021 and 20th October 2021 |
||||||||
f. |
Place of the transaction |
|
XLON (AIM) |
||||||||
Enquiries:
Inspiration Healthcare Group plc |
Tel: 01455 840 555
|
Cenkos Securities plc - Nominated Adviser & Broker |
Tel: 0207 397 8900
|
Cadogan PR
|
Tel: 07771 713 608
|
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has its own range of products for maintaining normothermia pre- during and post-surgery.
With product availability extending to over 75 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.
In the UK and Ireland, the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspirationhealthcaregroup.plc.uk